TAS-102 plus bevacizumab: a new standard for metastatic colorectal cancer?

Eng, C

Eng, C (corresponding author), Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.

LANCET ONCOLOGY, 2020; 21 (3): 326

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索